Author

Ora Gordon

Observed name: Ora K. Gordon

Institution: Providence Health & Services

Observed institutions: Providence Saint Joseph Medical Center, Saint John's Health Center, Providence Health & Services

ORCID: 0009-0002-2084-7914

Observed ORCID: 0009-0002-2084-7914

OpenAlex ID: A5135106501

Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer: A Multicenter Randomized Clinical Trial

2024 · Lorenzo Cohen, Suzanne C. Danhauer, et al. · JAMA Network Open · 42

Abstract PR002: Surveillance-detected pancreatic cancers: Updated report from the PRECEDE Consortium

2026 · Raymond Wadlow, Samuel Newton, et al. · Cancer Research · 1

Supplemental Figure S1 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Materials S2 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Table S5 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Table S2 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Table S1 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Materials S1 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Table S4 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Table S6 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Supplemental Table S3 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

Data from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al.

The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

2026 · Leigha Senter, Shelly Hovick, et al. · Cancer Prevention Research

Factors influencing patient discussion of genetic test results with health care providers: Insights from a hospital-based population genetic screening program

2026 · Lindsay Dickey, Kyle Jones, et al. · Genetics in Medicine

773 Evaluation of Blood-based Molecular Biomarker Test for the Surveillance of Individuals at High Risk for Pancreatic Cancer

2026 · Randall Brand, Aimee L. Lucas, et al. · Gastrointestinal Endoscopy

773 Evaluation of Blood-based Molecular Biomarker Test for the Surveillance of Individuals at High Risk for Pancreatic Cancer

2026 · Randall Brand, Aimee L. Lucas, et al. · Gastroenterology

Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?

2025 · Javier I. J. Orozco, Betsy J. Valdez, et al. · Annals of Surgical Oncology

Works count: 17

Citation count: 43

H-index: 1

I10-index: 1